Position in ACLX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$68,154,048
-$26,677,849 QoQ
Shares Held
593,573
-59.2% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. ACLX ranks #19 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in ACLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $68,154,048 | 593,573 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $94,831,897 | 1,454,477 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $72,453,493 | 882,503 | Shares | Other | 2025-11-26 | |
| 2025-06-30 | $64,333,340 | 976,968 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $44,842,911 | 683,581 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $17,213,528 | 224,456 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $20,887,769 | 250,123 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $14,424,399 | 261,359 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $38,374,210 | 551,750 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $33,406,170 | 601,913 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $20,232,694 | 563,899 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $10,353,586 | 327,438 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $16,920,758 | 549,197 | Shares | Other | 2023-05-18 | |
| 2022-12-31 | $23,049,055 | 743,998 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $2,872,146 | 153,018 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,252,875 | 124,606 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $59,809 | 4,266 | Shares | Defined | 2022-05-11 | |
| No filing history on record for this holder in this stock. | ||||||